Journal of Cancer and Medical Imaging

For Zeinab Ghasemishahrestani, publicly available academic profiles and publication records indicate the following education background:

• PhD (Doctor of Philosophy) – Biomedical / Medical Sciences
  Likely completed with research focus on dermatology, cancer biology, and wound healing
  (Associated with work linked to the University of Rio de Janeiro in Brazil)
• Postgraduate research / academic training – Dermatology and Biomedical Sciences
  Conducted during her research career, including work later associated with the University of Cape Town (South Africa) in skin biology and wound healing research
• Earlier academic studies (Bachelor’s/Master’s level)
  Reported in some research profiles as being in biomedical sciences / medical-related field, but exact institution details are not consistently listed in public records

Zeinab Ghasemishahrestani is a biomedical scientist and researcher specializing in cancer biology, biochemistry, and molecular medicine, with a focus on skin cancer, breast cancer, and nanotechnology-based therapies.

She completed her doctoral (PhD) training in biomedical sciences, with research conducted across institutions in Brazil (University of Rio de Janeiro) and later collaborations in South Africa (University of Cape Town) and other international research centers. Her academic work is strongly rooted in experimental biology, particularly studying how cancer cells behave and how they can be targeted using chemical and nanotechnological approaches.

Throughout her career, she has contributed to peer-reviewed scientific publications in areas such as:

• Cancer cell metabolism and signaling pathways
• Development of metal-based compounds for cancer treatment
• Nanoparticle-based drug delivery systems
• Skin cancer (melanoma) diagnosis and modeling
• Breast cancer proteomics and molecular mechanisms

She has collaborated with multidisciplinary teams of chemists, biologists, and medical researchers, and her work appears in international journals in oncology, biochemistry, and pharmaceutical sciences.

Her research is generally aimed at improving early cancer detection and developing more effective, targeted therapies with fewer side effects.

Zeinab Ghasemishahrestani’s research interests are mainly centered on cancer biology and translational biomedical science. Across her publications and academic work, her focus areas include:

• Cancer biology and oncology
  Studying how cancer cells grow, survive, and respond to treatment, especially in breast cancer and skin cancer (melanoma, keloid-related research).
• Cancer cell metabolism
  Investigating how cancer cells generate and use energy differently from normal cells, and how this can be targeted for therapy.
• Molecular and cellular biology
  Exploring signaling pathways, gene expression, and protein interactions involved in disease progression.
• Nanomedicine and drug delivery systems
  Designing and testing nanoparticles and metal-based compounds to improve targeted cancer treatment.
• Therapeutic drug development
  Evaluating new compounds for their anti-cancer, anti-proliferative, and apoptosis-inducing effects.
• Skin biology and wound healing
  Including research on keloid formation, tissue regeneration, and dermatological conditions.

Scientific Activities

• Peer-reviewed research publications
  She has authored and co-authored scientific papers in international journals focused on cancer biology, biochemistry, and biomedical sciences, particularly in areas like breast cancer, melanoma, and cellular metabolism.
• Cancer research investigations
  Actively involved in experimental studies on:
  • cancer cell growth and proliferation
  • molecular signaling pathways in tumors
  • mechanisms of drug resistance in cancer cells
• Nanotechnology and drug development research
  Participation in studies developing nanoparticle-based drug delivery systems and metal-based anti-cancer compounds aimed at improving targeted therapy.
• Laboratory-based experimental work
  Conducted in vitro (cell culture) experiments involving cytotoxicity testing, protein expression analysis, and molecular assays.
• Interdisciplinary collaboration
  Worked with researchers in chemistry, pharmacology, and medical sciences to develop multi-disciplinary approaches to cancer treatment.
• Conference participation and academic dissemination
  Presented research findings at scientific meetings and contributed to academic discussions in oncology and biomedical science fields.
• Focus on translational research
  Her work is oriented toward moving laboratory findings toward clinical applications, especially in cancer therapy development.

1. Cancer metabolism (review article)

• Pieces of the Complex Puzzle of Cancer Cell Energy Metabolism: An Overview of Energy Metabolism and Alternatives for Targeted Cancer Therapy
• Published in Current Medicinal Chemistry (2021)
• Focus: how cancer cells reprogram energy metabolism and potential therapeutic targets.

2. Keloid disease / wound healing research

• Subcellular Fractionation and Metaproteogenomic Identification… for Keloid Disease (2024/2025 publication timeline)
• Focus: molecular mechanisms and biomarkers involved in keloid formation.

3. Wound repair and phytochemicals

• African Medicinal Plants in Cutaneous Wound Repair: A Comprehensive Analysis… (2025)
• Focus: plant-derived compounds and their role in skin wound healing.

4. Breast cancer / proteomics-related work

• Publication on copper complexes affecting breast cancer proteome and cellular pathways.

5. Pre-eclampsia / obstetrics biomarker study

• Re-evaluating the clinical interpretation of sFlt-1/PlGF in diabetes-complicated preeclampsia (2026)
• Focus: biomarkers in pregnancy complications.

6. Conference work

• Work presented on keloid disease therapies and signaling pathways (conference proceedings, 2024).